Bioactive Compounds
-
B2240 OlanzapineTarget: 5-HT2 Receptors|D2 ReceptorsSummary: Antagonist of 5-HT2A and dopamine D2 receptors -
B1220 Tigecycline mesylateSummary: First-in-class, broad spectrum antibiotic -
B1652 7-Aminocephalosporanic acidSummary: Potent β-lactamase inhibitor -
B1366 Naftopidil DiHClSummary: Selective 5-HT1A and α1-adrenergic receptor antagonist -
A9040 IDF-11774 -
C6822 2,4-DihydroxybenzaldehydeSummary: An endogenous metabolite for metabolic disease and drug development -
C7121 2-AcetylpyrazineSummary: An intermediate for synthesizing nitrogen-containing heterocyclic drugs and vitamin derivatives -
N1704 Yohimbine HydrochlorideSummary: An α-2 adrenergic receptor antagonist that promotes norepinephrine release. -
B6947 Ionomycin free acid1 CitationTarget: Calcium ionophoresSummary: calcium ionophore -
B7535 Eeyarestatin ITarget: ERADSummary: inhibitor of endoplasmic reticulum-associated degradation (ERAD) and protein translocation

